We Announced the $48.3M Federal Partnership at the White House!
It was incredibly special for me to speak at the White House on Wednesday about our funding from the federal government and what it will mean for patients like me.
While on stage, I couldn’t help but think back to 14 years ago when I was fighting for my life in the ICU. I never could have imagined that one day I would be able to turn those horrible moments into a mission with the potential to help millions of patients all over the world.
The Wall Street Journal Profiled Our Repurposing Work to Help Patients like Kaila
Amy Marcus of the Wall Street Journal profiled Every Cure, the drug repurposing landscape, and patients like Kaila whose life was saved thanks to repurposed drugs that we uncovered! Click here to read the full article.
We are building an AI platform that aims to identify treatments for millions of patients
Every Cure is scaling the approach I used to discover my own cure to unlock additional life-saving uses for every drug. We are using the federal funding to leverage novel AI techniques to analyze the world’s biomedical knowledge and identify 100 potential treatment opportunities in the next five years and advance 25 into further research, including clinical trials. Promising early leads include arginine for sickle cell disease, folinic acid for autism spectrum disorder, and bosutinib for ALS.
You’ve probably seen the term “cytokine storm” in the news a lot recently. That’s because COVID19 is able to unleash a cytokine storm in the most sick cases. As someone who has survived 5 deadly COVID19-like cytokine storms due to idiopathic multicentric Castleman disease and who studies cytokine storms in my lab, I thought I’d…
When fighting a war, information really matters. You need to know what weapons have been tried and which ones have been most (and least) effective. This information helps soldiers to adjust their strategy. The same holds true when fighting a global war against a disease like COVID19 (or Castleman disease or any disease!). We need…
Congress should encourage companies to repurpose existing drugs for rare diseases, potentially doubling the number of treatment options for patients. Lately, there has been a national uproar over the rising cost of medicine in the U.S. While this is an important public debate, it largely overlooks the critical importance of innovation, which is desperately needed…
[embedyt] https://www.youtube.com/watch?v=0HFHfTd9-Y8[/embedyt] Check out the above video about our COVID19 drug repurposing work or go to: https://youtu.be/0HFHfTd9-Y8 Thank you to Jimmy Baggott for making this amazing video! #ThinkItDoIt #FromHopeToAction #ChasingMyCure #ChasingCOVIDsCure David Fajgenbaum, MD, MBA, MSc, is a groundbreaking physician-scientist, disease hunter, speaker, and bestselling author of the acclaimed memoir, Chasing My Cure: A…
Our family grew! We welcomed our second little one into the world On November 5, 2021, we welcomed baby David into the world. He is the sweetest little brother to Amelia. It feels like such a dream to have this incredible family when I think back to when I was on my deathbed 13 years…